Abiopharma

🔍 KELLY GARY C (Executive)

Company: LINCOLN NATIONAL CORP (LNC)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 1,268 shares of Phantom Stock Unit (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: false | shares_owned_after: 110,769.88 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each Phantom Stock Unit is the equivalent of one share of LNC Common Stock.
• F2: Quarterly payment of board retainer and fees in shares of phantom stock accrued under the LNC Deferred Compensation Plan for Non-employee Directors (the "Directors' DCP") in the LNC Stock Fund investment account, which are payable solely in shares of LNC Common Stock at resignation or retirement. The reporting person may transfer his/her phantom stock unit holdings into an alternative investment account in the Directors' DCP at any time.